Impact and reversal of life-threatening bleeds
Thursday, March 18th, 2021 | 11:00 AM - 12:00 PM CT
This program will discuss the burden of life-threatening bleeds related to FXa inhibitors, and focus on the mechanism of action, efficacy and safety of reversal for patients on apixaban or rivaroxaban with life-threatening bleeding, as well as provide an overview of clinical guidelines for treating FXa inhibitor-related major bleeds.
Niels D. Martin, MD, FACS, FCCM
Associate Professor of Surgery, Hospital of the University of Pennsylvania, Presbyterian Medical Center of Philadelphia
Please see additional Important Safety Information here.